Ulcer meds get new FDA warning; Roche faulted for lack of women in top management;

@FiercePharma: Novartis MS pill gets boost from Merck rejection. Report | Follow @FiercePharma

 > Prescription ulcer drugs such as AstraZeneca's blockbuster Nexium will carry a new warning that long-term use may cause low magnesium levels, the FDA said. Article

> Roche gained shareholder backing to appoint the chief executives of three major European companies to its board, but faced criticism from some investors who want the company to appoint more women to its top management level. Story

> A U.S. law firm is taking a class action suit against Irish pharmaceutical developer Elan, claiming that a deal it did with multinational Johnson & Johnson caused shareholders to lose money. Item

> Johnson & Johnson's antipsychotic medicine Risperdal Consta, its third-best-selling drug, fared no better than less expensive treatments at keeping schizophrenia patients out of the hospital, U.S. researchers said. News

> Aspen Pharmacare, the largest maker of generic medicines in the Southern Hemisphere, said fiscal first-half profit jumped 31 percent as revenue from its businesses in sub-Saharan Africa more than doubled. Report

> The World Health Organization expects global vaccine supplies will benefit significantly after it approved the Chinese SFDA regulatory system. Article

Biotech News

 @FierceBiotech: Fresh signs of a biotech buyout blast in 2011. Item  | Follow @FierceBiotech

@JohnCFierce:  Merck KGaA's clinical approach on cladribine was all wrong. A classic Ph3 mistake, which Novartis managed to avoid. News | Follow @JohnCFierce 

> Lycera snags $307M anti-inflammatory discovery deal with Merck. Story

> Bydureon fails head-to-head trial with Novo's Victoza. Item 

> Vertex boosted by new round of promising telaprevir data. Report

> Renovo axing 100, auctioning assets after Shire bails on failed Juvista program. News 

> Foiled in U.S., InterMune wins EU approval for pirfenidone. Item 

> Sanofi begins to scope out where it will cut, add at Genzyme. News

Vaccines News

> Anti-cancer drug could be anti-flu too. Article

> Novavax's VLP tech gets HHS funding for flu vaccine. Report 

> Baxter's Preflucel gets EU OK. Story 

> Inovio gets good news against foot-and-mouth disease. News

>  Scientists: HIV vaccine impacts the genetic makeup of the virus. Report

Manufacturing News

> Drugmaker finds eco-friendly building stain remover. Article

> Africa tops China for drug variability. News

> Dendreon busts out of biotech with capacity boost. Report 

> Pharmacists compound liquid Tamiflu supply. Item 

> WHO oks China as vax regulator. News

> Triad recall moves Form 483 to limelight. Story

And Finally... Type 2 diabetes is linked to a single gene mutation in one-tenth of patients. Report

Suggested Articles

Six pharmaceutical execs are set to head to Washington next week for pricing hearings at the House Committee on Oversight and Reform. 

After sifting through the data, one analyst figures the latest Opdivo-Keytruda showdown in kidney cancer might come down to commercial execution.

Biogen is giving former chief finance officer Jeff Capello a multimillion-dollar cash payment plus other severance benefits.